Skip to main content
. 2019 Jul 1;2019(7):CD011621. doi: 10.1002/14651858.CD011621.pub3

Tomas 2016.

Methods Simulation study, randomised control trial; parallel groups
How was the simulation performed?
Participants removed improved gowns and gloves in their usual manner.
How was the exposure simulated?
Gloved hands were inoculated with 0.5 mL phosphate‐buffered saline (PBS) containing 10^10 plaque‐forming units of MS2 and 0.5 mL fluorescent lotion and the solutions were rubbed over the gloved hands until dry. Bacteriophage MS2 was of the type 15597‐B1 (American Type Culture Collection,VA).
Participants N = 30 Healthcare personnel; No other information provided; asked authors for more information.
Interventions Intervention: A seamless PPE prototype in which adhesive material on the outer sleeve of the gown at the wrist attaches to the inner cuff of the gloves, providing continuous coverage of the wrist and hand. This design prevents exposure of skin and requires that gloves be peeled off as the gown is removed. The prototype seamless PPE consisted of polyethylene contact isolation gowns (SafetyPlus Polyethylene Gown, TIDI Products, Neenah, WI) and nitrile gloves (Denville Scientific, South Plainfield, NJ).Permanent contact bond adhesive (DAP Weldwood Contact Cement, DAP Products, Baltimore, MD) was applied circumferentially to the outer gown at the level of the wrist.Gloves were pressed to the gowns for 15 minutes and allowed to air dry for 24 hours.
Control: Only described as standard PPE and assumed as gloves and gown
Outcomes 1. Outcome assessment fluorescent: Hand and wrist skin contamination with the fluorescent lotion was assessed using a black light (Ultra Light UV1 by Grizzly Gear, SCS Direct,Trumball, CT).
2. Outcome assessment Bacteriophage: Participants then wiped both hands and wrists with a sterile, pre‐moistened 4 × 4 gauze pad that was placed into a sterile container containing 10 mL PBS and mixed in a vortex mixer for 1 minute to elute the bacteriophage. Aliquots of each elutant were serially diluted and cultured to quantify virus particles.
Notes Location: USA; Funding was provided by the Department of Veteran Affairs; One author, C.J.D. had previously received research grants from Clorox, Merck, AvidBiotics and GOJO and the same author also served on scientific advisory boards for 3M and Seres Health.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "Healthcare personnel were randomized to perform simulations of contaminated glove removal"; authors asked for method of generation
Allocation concealment (selection bias) Unclear risk unclear if irrevocable
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Not blinded but objectively measured outcome
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No information provided
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk No information on missing data provided
Selective reporting (reporting bias) Unclear risk No protocol published
Other bias Low risk No other biases detected